Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan
· Delayed Price · Currency is JPY 2,094.00
-56.00 (-2.60%)
Mar 10, 2025, 3:30 PM JST
Daito Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 7, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2019 - 2015 |
| Market Capitalization | 32,681 | 34,043 | 33,086 | 37,154 | 44,980 | 56,950 | Upgrade
|
| Market Cap Growth | 4.54% | 2.89% | -10.95% | -17.40% | -21.02% | 35.25% | Upgrade
|
| Enterprise Value | 40,765 | 37,799 | 34,956 | 37,065 | 46,116 | 58,118 | Upgrade
|
| Last Close Price | 2146.00 | 2188.83 | 1999.65 | 2218.60 | 2718.74 | 3565.94 | Upgrade
|
| PE Ratio | 12.50 | 10.33 | 9.19 | 7.96 | 10.59 | 14.44 | Upgrade
|
| Forward PE | 13.40 | 8.98 | 9.38 | 8.00 | 10.05 | 17.46 | Upgrade
|
| PS Ratio | 0.70 | 0.73 | 0.73 | 0.85 | 0.92 | 1.27 | Upgrade
|
| PB Ratio | 0.63 | 0.65 | 0.65 | 0.78 | 1.07 | 1.54 | Upgrade
|
| P/TBV Ratio | 0.62 | 0.66 | 0.66 | 0.79 | 1.09 | 1.57 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 36.16 | Upgrade
|
| P/OCF Ratio | 6.33 | 6.57 | 7.96 | 8.50 | 8.68 | 13.23 | Upgrade
|
| EV/Sales Ratio | 0.86 | 0.81 | 0.78 | 0.85 | 0.95 | 1.29 | Upgrade
|
| EV/EBITDA Ratio | 5.71 | 5.00 | 3.85 | 3.75 | 5.08 | 6.99 | Upgrade
|
| EV/EBIT Ratio | 13.28 | 9.71 | 6.71 | 5.64 | 7.80 | 10.84 | Upgrade
|
| EV/FCF Ratio | -16.95 | - | - | - | - | 36.90 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.17 | 0.10 | 0.07 | 0.08 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 1.58 | 1.15 | 0.55 | 0.35 | 0.37 | 0.38 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 2.01 | Upgrade
|
| Asset Turnover | 0.61 | 0.63 | 0.67 | 0.71 | 0.87 | 0.89 | Upgrade
|
| Inventory Turnover | 1.87 | 1.89 | 1.98 | 1.97 | 2.72 | 3.20 | Upgrade
|
| Quick Ratio | 1.25 | 1.05 | 1.38 | 1.46 | 1.26 | 1.24 | Upgrade
|
| Current Ratio | 2.50 | 2.24 | 2.64 | 2.69 | 2.52 | 2.05 | Upgrade
|
| Return on Equity (ROE) | 4.61% | 6.16% | 7.15% | 10.33% | 10.55% | 11.51% | Upgrade
|
| Return on Assets (ROA) | 2.49% | 3.28% | 4.81% | 6.69% | 6.60% | 6.64% | Upgrade
|
| Return on Capital (ROIC) | 3.12% | 4.16% | 6.09% | 8.51% | 8.67% | 8.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.95% | 6.58% | 9.46% | 12.91% | 13.18% | 13.68% | Upgrade
|
| Earnings Yield | 8.11% | 9.68% | 10.88% | 12.56% | 9.44% | 6.93% | Upgrade
|
| FCF Yield | -7.36% | -3.05% | -4.08% | -0.69% | -2.53% | 2.77% | Upgrade
|
| Dividend Yield | 3.30% | 2.74% | 2.73% | 2.05% | 1.54% | 1.02% | Upgrade
|
| Payout Ratio | 35.46% | 27.53% | 25.86% | 14.14% | 15.50% | 12.73% | Upgrade
|
| Buyback Yield / Dilution | 2.32% | 0.86% | -3.38% | -1.94% | -6.41% | -2.53% | Upgrade
|
| Total Shareholder Return | 5.62% | 3.61% | -0.66% | 0.11% | -4.88% | -1.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.